Diabetes and cardiometabolic buyers – patients, clinicians, and payers – have been let down by overpromising health companies before you arrived. We create a brand strategy with trust as the asset, evidence as the foundation, and every element designed to earn belief in a skeptical category.
The Challenge
Trust is the real product, yet most brand work overlooks it
In diabetes and cardiometabolic health, a buyer is deciding whether to trust you with their health or their members' health, and no amount of visual polish substitutes for credibility. Brand exercises that focus on logo, palette, and tone while ignoring how the company earns belief solve the wrong problem. In this category, a brand strategy that does not put trust at the center is decoration, and decoration does not close skeptical health buyers.
The category has conditioned buyers to anticipate overpromising
Patients and clinicians have watched metabolic-health companies promise to reverse disease and then underdeliver, so they arrive already discounting your claims. A brand that leans into hype inherits that skepticism and amplifies it, while a brand that leads with honest, evidence-grounded confidence stands out precisely because the category has trained people to expect the opposite. Winning here means positioning against the category's own credibility problem, which most brand strategies never even name.
Your brand must withstand clinical and regulatory scrutiny
Unlike a consumer app, a cardiometabolic brand gets read by medical reviewers, compliance teams, and clinical partners who will reject a brand promise that outruns the evidence. A brand strategy that makes claims the company cannot substantiate is not just off-message, it is a liability that clinical partners and payers will hold against you. Building a brand that is both compelling and defensible is a constraint most brand shops are not equipped to work inside.
Without a brand strategy, every decision gets re-litigated
Without a defined brand strategy, every new campaign, partnership, and product launch reopens the same arguments about who you are and what you stand for, wasting time and producing inconsistency. In a fast-moving category, that internal drag slows you down while competitors with a clear brand move faster and land harder. The absence of a strategic anchor turns each decision into a debate and each debate into lost momentum.
How We Help
We begin by clarifying what your brand truly stands for and how it earns trust – the belief you want a skeptical patient, clinician, or payer to have, along with the evidence and behavior that would support it. In a category where trust is the product, this becomes the strategic core, and we resolve it before beginning any expression work within our broader [growth strategy](/services/strategy/) practice.
We then develop the brand strategy: your position relative to the category's credibility problem, a brand promise calibrated to what you can genuinely substantiate, and a personality that makes honest confidence feel distinctive rather than clinical and cold. We position you in opposition to the overpromising buyers have been conditioned to expect, because that is where differentiation lies.
Execution turns the strategy into a brand system – narrative, tone, and expression – developed through our [marketing](/services/marketing/) practice and stress-tested under clinical and regulatory scrutiny so the brand promise never exceeds the evidence. The goal is to be compelling and defensible simultaneously, which is the particular skill this category requires.
We also create brand guidelines and a decision framework that keep every campaign and partnership from re-litigating who you are, allowing the organization to move faster around a shared anchor. This turns brand from a one-off project into a tool the team uses for quicker, more consistent decisions.
Measurement centers on what matters here – whether trust and credibility are truly increasing among your audiences – tracked through brand perception and its downstream impact on conversion and retention using our [measurement](/services/measurement/) layer, rather than aesthetic preference.
We are not refreshing your logo and labeling it brand strategy – we are creating the trust architecture that a skeptical, regulated health category demands.
What we deliver
- A brand foundation centered on how you earn trust, not how you look
- Positioning against the category's overpromising and credibility problem
- A brand promise calibrated to what you can actually substantiate
- A brand system – narrative, tone, expression – that is compelling and defensible
- Brand guidelines and a decision framework the whole team operates from
- Trust-based measurement tied to conversion and retention, not aesthetics
In diabetes and cardiometabolic health, the category has already conditioned your buyers to distrust health claims – so the winning brand does not out-promise the field; it counters overpromising with evidence-grounded confidence, turning honesty itself into the differentiator.
Our Methodology
Our 90-day sprint creates a brand strategy organized around trust as the central asset. Days 1-30 focus on assessment: we examine how your patients, clinicians, and payers develop trust, audit the category's credibility problem and competitors' positioning against it, catalog what you can authentically substantiate, and pinpoint where your existing brand either overpromises or does not differentiate. This phase concludes with a brand foundation direction and substantiation inventory.
Days 31-60 focus on execution. We establish the position, brand promise, and personality, then create the brand system – narrative, tone, and expression – while stress-testing every promise against clinical and regulatory scrutiny. We present the work for medical, compliance, and stakeholder review, ensuring the brand is both compelling and defensible instead of sacrificing one for the other.
Days 61-90 cover rollout and measurement setup. We complete the guidelines and decision framework, support the team's adoption of the brand across surfaces, and establish brand-perception tracking so you can monitor trust and credibility over time. Since brand strategy influences every downstream decision, the sprint is designed to install an enduring system, not produce a document that gathers dust.
How We Work
During the first 30 days, we collaborate with your founder, clinical or medical lead, and compliance reviewer, because a trust-centered brand promise must be rooted in what you can substantiate. Expect working sessions that clarify what the brand stands for, assess the category's credibility problem, and distinguish defensible promises from aspirational ones.
Days 30-60 shift to developing the brand system. Instead of refreshing a logo, we create the narrative, promise, and expression, testing every promise through clinical and regulatory review and presenting the work for stakeholder approval. We maintain the compelling-and-defensible standard throughout, revising anything that extends beyond the evidence.
Days 60-90 center on rollout and measurement. We complete the guidelines and decision framework, help drive adoption across the organization, and implement brand-perception tracking connected to conversion and retention. Since brand work compounds and only matters when adopted, most engagements last 3-5 months to install and embed the system, rather than merely deliver it.
The team includes a strategist responsible for the brand foundation and positioning, a content and design resource who develops the expression system, and a measurement resource who monitors brand perception – scaled according to the rebrand or refinement scope rather than a fixed package.
- A brand buyers actually believe in a skeptical category
- Differentiation built on honest, evidence-grounded confidence
- A brand promise that holds up under clinical and regulatory scrutiny
- Faster, more consistent decisions from a shared brand anchor
- Rising trust and credibility tracked through conversion and retention
If your diabetes & cardiometabolic health company needs brand strategy leadership, we should talk.
Expand your marketing team output with our experts
Let us take a custom approach to your growth goals by assembling and leading the best-in-class marketing team to support your next stage.
Frequently asked questions
What does a brand strategy engagement cost for a diabetes or cardiometabolic company?
Engagements generally cost $15K-$35K/month, based on whether the work is a complete rebrand or strategic refinement and the amount of expression work required. Pricing reflects the brand system's scope and the depth of substantiation and testing, rather than a fixed list of deliverables. Because brand strategy guides every downstream decision and marketing dollar, the investment is evaluated against the efficiency and trust it creates throughout the business.
Why does trust sit at the center of brand strategy in this category?
Because buyers are deciding whether to entrust you with their health or their members' health, and visual polish cannot replace credibility. Patients and clinicians have been disappointed by overpromising metabolic-health companies, so they are skeptical of claims before encountering you. A brand strategy that prioritizes the logo and palette over how you earn belief addresses the wrong problem in a category where trust is the actual product.
How can you make a brand stand out without overpromising?
We position you in opposition to the category's credibility problem – emphasizing honest, evidence-grounded confidence rather than louder health claims – which stands apart precisely because buyers anticipate the reverse. The brand promise is aligned with what you can genuinely substantiate, ensuring it never exceeds the evidence. In a field conditioned to expect hype, disciplined honesty becomes a differentiator instead of a constraint.
How do you ensure the brand remains defensible through clinical and regulatory review?
During the build, we stress-test each brand promise against clinical and compliance scrutiny, bringing in your medical and regulatory stakeholders before anything launches. A brand claim that exceeds the evidence creates a liability that clinical partners and payers will count against you, so we maintain a compelling-and-defensible standard rather than picking one over the other. That rigor is fundamental to the work, not merely a final legal review.
How does brand strategy help us make decisions faster?
We develop brand guidelines and a decision framework that provide the team with a common anchor, so each new campaign, partnership, and launch does not re-litigate who you are. Without this anchor, every decision restarts the same discussion and creates inconsistency that undermines trust. With it, the organization moves more quickly and lands with greater impact because the brand has made the argument in advance.
What does it look like to get started with brand strategy?
We start by examining how your audiences build trust, assessing the category's credibility problem, and cataloging what you can authentically substantiate. This reveals where your existing brand overpromises or lacks differentiation and establishes a clear direction for the foundation. If your diabetes or cardiometabolic company is having difficulty earning belief in a skeptical category, we should talk.
